FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

486111000001109: Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17582101000001118 Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17582201000001113 Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Is a Nystatin 100,000 units/ml oral suspension sugar free false Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Local anti-infective false Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Skin antifungal agent false Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Nystatin true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Is a Nystatin 100,000units/ml oral suspension sugar free true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has active ingredient Skin anti-infective false Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Is a Nystamont true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has specific active ingredient Nystatin true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Is a Nystatin 100,000units/ml oral suspension sugar free false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) 30 ml Is pack of False Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) 30 ml Has AMP True Nystamont 100,000units/ml oral suspension (Rosemont Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start